S. 849 would authorize the Centers for Disease Control and Prevention (CDC) to provide grants to states and U.S. territories to prevent and control emerging mosquito-borne diseases. The bill would authorize the appropriation of a total of $290 million for each of fiscal years 2018 through 2022 to carry out those activities: $100 million a year for the Mosquito Abatement for Safety and Health program and $190 million a year for Epidemiology Laboratory Capacity (ELC) grants.
CBO estimates that implementing S. 849 would cost $1.2 billion over the 2018-2022 period, assuming appropriation of the authorized amounts. Enacting S. 849 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.
CBO estimates that enacting the legislation would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2028.
S. 849 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.